| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-26,836 | -20,916 | -20,742 | -19,436 | -31,783 | -15,443 | -9,756 | -11,826 | -9,012 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
2,155 | 1,809 | 1,401 | 1,168 | 939 | 799 | 585 | 512 | 458 |
Share-based compensation | ||||||||
3,105 | 2,621 | 2,491 | 2,279 | 1,549 | 1,756 | 292 | 255 | 150 |
Loss on disposal of property, equipment, and software | ||||||||
- | - | - | - | - | -6 | 0 | -2 | -6 |
Non-cash interest expense | ||||||||
- | 0 | 0 | 0 | 182 | - | - | - | - |
Change in fair value of convertible notes payable | ||||||||
- | 0 | 0 | -2,950 | 12,708 | - | - | - | - |
Amortization of right-of-use assets | ||||||||
235 | - | - | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | ||||||||
-1,635 | -1,242 | 2,474 | -35 | -613 | -1,158 | 5,444 | -1,758 | 4,948 |
Accounts receivable | ||||||||
2,894 | 714 | 0 | -5,907 | 5,634 | - | - | - | - |
Other assets and other current assets | ||||||||
-1,411 | - | - | - | 141 | - | - | - | - |
Other assets | ||||||||
- | - | - | - | - | - | - | 5 | 25 |
Accounts payable | ||||||||
-266 | 70 | 390 | -1,274 | 1,481 | -1,626 | 719 | -121 | 355 |
Accrued other expenses and other current liabilities | ||||||||
-916 | - | - | - | -768 | - | - | - | - |
Accrued expenses | ||||||||
- | - | - | - | - | - | - | 1,523 | -217 |
Deferred revenue | ||||||||
-3,139 | -6,274 | 2,280 | -4,819 | 947 | -4,473 | 3,925 | -1,408 | -1,221 |
Lease liabilities and right-of-use assets | ||||||||
400 | - | - | - | - | - | - | - | - |
Net cash used in operating activities | ||||||||
-25,910 | -20,556 | -13,977 | -16,575 | -19,907 | -12,912 | -15,047 | -9,310 | -14,454 |
Cash flows from investing activities: | ||||||||
Purchases of property, equipment and software | ||||||||
1,103 | 5,529 | 5,918 | 8,137 | 5,082 | 9,871 | 2,660 | 1,128 | 619 |
Net cash used in investing activities | ||||||||
-1,103 | -5,529 | -5,918 | -8,137 | -5,082 | -9,871 | -4,045 | -1,128 | -619 |
Cash flows from financing activities: | ||||||||
Proceeds from stock option exercises | ||||||||
212 | 821 | 61 | 272 | 107 | 62 | 27 | 62 | 20 |
Proceeds from employee stock purchase plan | ||||||||
239 | - | - | - | - | - | - | - | - |
Deferred offering costs | ||||||||
137 | 115 | 0 | 1,145 | 1,362 | - | - | - | - |
Issuance of convertible notes | ||||||||
- | 0 | 0 | 0 | 39,550 | - | - | - | - |
Net cash provided by financing activities | ||||||||
314 | 706 | 61 | 134,312 | 38,295 | -1,592 | 21,317 | 88,032 | 20 |
Net increase (decrease) in cash and cash equivalents | ||||||||
-26,699 | -25,379 | -19,834 | 109,600 | 13,306 | -24,375 | 2,225 | 77,594 | -15,053 |
Supplemental disclosures of noncash financing and investing activities: | ||||||||
Property, equipment and software additions included in accounts payable, accrued expenses and other current liabilities | ||||||||
651 | -3,123 | 1,472 | -1,899 | 3,951 | -847 | 1,099 | 436 | 652 |
Deferred offering costs included in accounts payable, accrued expenses and other current liabilities | ||||||||
66 | - | - | - | 800 | - | - | - | - |